Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:44 PM
Ignite Modification Date:
2025-12-24 @ 7:44 PM
NCT ID:
NCT00889603
Eligibility Criteria:
Inclusion Criteria:
* Outpatients (male / female), older than 50 years.
* Patients with clinical symptoms of mild and moderate AD and Vascular Dementia.
* MMSE score between 12 - 24.
Exclusion Criteria:
* Patients with a known hypersensitivity to donepezil clorhydrat, piperidine derivatives or any of the excipients of Aricept® Evess.
* Patients with severe impaired hepatic function.
* Patients with pre-existing gastrointestinal ulcer disease.
* Patients with the history of bronchial asthma or chronic obstructive lung disease.
* Patients with the history of serious atrioventricular conduction disturbances.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT00889603
Study Brief:
Protocol Section:
NCT00889603